US Stem Cell Inc (USRM)

[docprep]

This is a clinical biotechnology company. The fact there is ANY revenue, no matter heavily increasing revenue is highly unexpected (but of course thoroughly welcome), and the company is on the cusp of completing the government red tape to bring the potential to the kinetic, and be overwhelmingly profitable.

Whether this company markets the therapy themselves, licenses it out, educates it out, or gets bought out, the longs and believers will be rewarded, as well as anyone who knows that these types of therapies are long overdue to be in the mainstream, held back only by the powers that be, government, and big pharma.

And for the record I don't work for a bk firm. Bankruptcy is about 5% of what we do.

And I'm glad I'm educated and can see potential in smart investment.

(Didn't need to be hired by a shorting interested company and ho yo trade school to learn html to know that)